Comment j'explore... Une anémie. I = How to manage an anemiaBEGUIN, Y.RMLG. Revue médicale de Liège. 1995, Vol 50, Num 10, pp 443-444, issn 0370-629XArticle

A risk-benefit assessment of epoetin in the management of anaemia associated with cancerBEGUIN, Y.Drug safety. 1998, Vol 19, Num 4, pp 269-282, issn 0114-5916Article

Comment j'explore... une anémie. II = Managment of anemiaBEGUIN, Y.RMLG. Revue médicale de Liège. 1995, Vol 50, Num 11, pp 487-488, issn 0370-629XArticle

Pharma Clinics. Comment je traite... une anémie. III = Anemia treatmentBEGUIN, Y.RMLG. Revue médicale de Liège. 1995, Vol 50, Num 12, pp 497-498, issn 0370-629XArticle

Une expérience d'enseignement individualisé de l'anglais langue seconde à l'élémentaireBEGUIN, Y.Working Papers on Bilingualism Toronto. 1979, Num 18, pp 165-178Article

Erythropoietin and platelet productionBEGUIN, Y.Haematologica - Journal of hematology. 1999, Vol 84, Num 6, pp 541-547Article

Prediction of response to optimize outcome of treatment with erythropoietinBEGUIN, Y.Seminars in oncology. 1998, Vol 25, Num 3, pp 27-34, issn 0093-7754, SUP7Conference Paper

Erythropoietin and the anemia of cancerBEGUIN, Y.Acta Clinica Belgica. 1996, Vol 51, Num 1, pp 36-52, issn 0001-5512Article

La greffe de cellules souches hématopoïétiques (greffe de moelle osseuse) : Indications, Modalités et risques = Bone marrow graftBEGUIN, Y.RMLG. Revue médicale de Liège. 1996, Vol 51, Num 4, pp 270-275, issn 0370-629XArticle

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantationBARON, F; BEGUIN, Y.Transfusion (Philadelphia, PA). 2000, Vol 40, Num 4, pp 468-476, issn 0041-1132Article

Minitransplants: Allogeneic stem cell transplantation with reduced toxicityBEGUIN, Y; BARON, F.Acta Clinica Belgica. 2003, Vol 58, Num 1, pp 37-45, issn 0001-5512, 9 p.Article

Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancerBEGUIN, Y.Medical oncology (Northwood). 1998, Vol 15, pp S38-S46, issn 1357-0560, SUP1Article

New tools for clinical evaluation of erythron function in manCAZZOLA, M; BEGUIN, Y.British journal of haematology. 1992, Vol 80, Num 3, pp 278-284, issn 0007-1048Article

GVHD chronique et effet antitumoral : La réaction chronique du greffon contre l'hôte = Chronic GVHD and graft versus tumor effectsBARON, F; BEGUIN, Y.Correspondances en onco-hématologie. 2010, Vol 5, Num 1, pp 12-16, issn 1954-4820, 5 p.Article

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supplyLOO, M; BEGUIN, Y.Blood. 1999, Vol 93, Num 10, pp 3286-3293, issn 0006-4971Article

Complications hépatiques de la chimiothérapie : De la cytolyse banale à la maladie veine-occlusive du foie = Hepatotoxicity of chemotherapeutic agentsBARON, F; BEGUIN, Y.RMLG. Revue médicale de Liège. 1997, Vol 52, Num 2, pp 93-97, issn 0370-629XArticle

COMMENT J'EXPLORE ... une fièvre d'origine indéterminée chez le patient adulte ? = HOW TO EXPLORE... A FEVER OF UNKNOWN ORIGIN IN ADULT PATIENTS?VERTENOEIL, G; SERVAIS, S; BEGUIN, Y et al.RMLG. Revue médicale de Liège. 2012, Vol 67, Num 7-8, pp 391-397, issn 0370-629X, 7 p.Article

MALADIE DU GREFFON CONTRE L'HÔTE CHRONIQUE: une prise en charge multidisciplinaire = CHRONIC GRAFT-VERSUS-HOST DISEASE: A MULTIDISCIPLINARY APPROACHSERVAIS, S; WILLEMS, E; BEGUIN, Y et al.RMLG. Revue médicale de Liège. 2010, Vol 65, Num 2, pp 81-87, issn 0370-629X, 7 p.Article

Transfusions after nonmyeloablative or reduced-intensity conditioning regimensBARON, F; VANSTRAELEN, G; BEGUIN, Y et al.Leukemia. 2006, Vol 20, Num 12, pp 2081-2086, issn 0887-6924, 6 p.Article

The veno-occlusive disease of the liverBARON, F; DEPREZ, M; BEGUIN, Y et al.Haematologica (Roma). 1997, Vol 82, Num 6, pp 718-725, issn 0390-6078Article

Serum erythropoietin in chronic lymphocytic leukaemiaBEGUIN, Y; LAMPERTZ, S; BRON, D et al.British journal of haematology. 1996, Vol 93, Num 1, pp 154-156, issn 0007-1048Article

CANCERS SECONDAIRES APRÈS ALLOGREFFE DE CELLULES SOUCHES HÉMATOPOÏÉTIQUES = SECONDARY MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIONHAFRAOUI, K; BEGUIN, Y; BARON, F et al.RMLG. Revue médicale de Liège. 2009, Vol 64, Num 10, pp 496-499, issn 0370-629X, 4 p.Article

Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietinFILLET, G; BEGUIN, Y.Acta Clinica Belgica. 2001, Vol 56, Num 3, pp 146-154, issn 0001-5512Conference Paper

Traitement des myélomes réfractaires par la thalidomide = Thalidomide for treatment of refractory multiple myelomaSAUTOIS, B; SCERBO, F; BEGUIN, Y et al.Médecine et hygiène. 2000, Vol 58, Num 2311, pp 1633-1634, issn 0025-6749Article

Perspectives diagnostiques et thérapeutiques de l'érythropoïétine = Diagnostic and therapeutic perspectives of erythropoietinBEGUIN, Y; STAUTOIS, B; FILLET, G et al.Médecine et hygiène. 1991, Vol 49, Num 1897, pp 2034-2040, issn 0025-6749, 4 p.Article